×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Precision Medicine Market Forecast 2027 By Product Type (Diagnostics {Genetic Tests, Biomarker Based Tests}, Therapeutics), By Application (Oncology, CNS, Immunology, Respiratory), By End-use (Hospitals, Diagnostic Centers, Research & Academic Institutes), Research Report, Country Outlook (China, Japan, India, South Korea, Australia, Singapore, Taiwan, Hong Kong, Indonesia), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: September 2021   |   Report ID: GR1952   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology

    1.1    Definition and forecast parameters

    1.1.1    Definitions

    1.1.2    Methodology and forecast parameters

    1.2    Data sources

    1.3    References & sources

    1.3.1    Secondary

    1.3.2    Primary

    Chapter 2   Executive Summary

    2.1    Asia Pacific precision medicine industry summary, 2016 - 2027

    2.1.1    Country trends

    2.1.2    Product type trends

    2.1.3    Application trends

    2.1.4    End-use trends

    Chapter 3   Industry Insights

    3.1    Industry segmentation

    3.2    Industry outlook, 2016 - 2027

    3.3    Major factor analysis

    3.3.1    Growth drivers

    3.3.1.1    Advancements in cancer biology in Asia Pacific

    3.3.1.2    Expanding portfolio of precision medicine drugs

    3.3.1.3    Rise in online collaborative forums

    3.3.1.4    Increasing adoption of gene therapy

    3.3.2    Restraints & challenges

    3.3.2.1    High cost of precision medicines

    3.3.2.2    Violation of privacy rule and potential threat to personal health data

    3.3.2.3    Stringent regulatory norms

    3.4    COVID-19 impact analysis

    3.5    Porter’s analysis

    3.6    Competitive review, 2020

    3.7    PEST analysis

    Chapter 4   Asia Pacific Precision Medicine Market, By Product Type

    4.1    Key trends in Asia Pacific precision medicine, by product type

    4.2    Diagnostics

    4.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    4.2.2    Genetic tests

    4.2.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    4.2.3    Biomarker based tests

    4.2.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    4.2.4    Others

    4.2.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    4.3    Therapeutics

    4.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    Chapter 5   Asia Pacific Precision Medicine Market, By Application

    5.1    Key trends in Asia Pacific precision medicine, by application

    5.2    Oncology

    5.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    5.3    CNS

    5.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    5.4    Immunology

    5.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    5.5    Respiratory

    5.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    5.6    Others

    Chapter 6   Asia Pacific Precision Medicine Market, By End-use

    6.1    Key trends in Asia Pacific precision medicine, by end-use

    6.2    Hospitals

    6.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    6.3    Diagnostic centers

    6.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    6.4    Research and academic institutes

    6.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    6.5    Others

    6.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

    Chapter 7   Asia Pacific Precision Medicine Market, By Country

    7.1    Key trends in Asia Pacific precision medicine, by country

    7.2    Japan

    7.2.1    Market estimates and forecast, by product type, 2016 - 2027

    7.2.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.2.2    Market estimates and forecast, by application, 2016 - 2027

    7.2.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.3    China

    7.3.1    Market estimates and forecast, by product, 2016 - 2027

    7.3.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.3.2    Market estimates and forecast, by application, 2016 - 2027

    7.3.3    Market estimates and forecast, by end-use, 2016 – 2027

    7.4    India

    7.4.1    Market estimates and forecast, by product type, 2016 - 2027

    7.4.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.4.2    Market estimates and forecast, by application, 2016 - 2027

    7.4.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.5    Australia

    7.5.1    Market estimates and forecast, by product, 2016 - 2027

    7.5.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.5.2    Market estimates and forecast, by application, 2016 - 2027

    7.5.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.6    South Korea

    7.6.1    Market estimates and forecast, by product type, 2016 - 2027

    7.6.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.6.2    Market estimates and forecast, by application, 2016 - 2027

    7.6.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.7    Singapore

    7.7.1    Market estimates and forecast, by product, 2016 - 2027

    7.7.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.7.2    Market estimates and forecast, by application, 2016 - 2027

    7.7.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.8    Taiwan

    7.8.1    Market estimates and forecast, by product type, 2016 - 2027

    7.8.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.8.2    Market estimates and forecast, by application, 2016 - 2027

    7.8.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.9    Hong Kong

    7.9.1    Market estimates and forecast, by product, 2016 - 2027

    7.9.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.9.2    Market estimates and forecast, by application, 2016 - 2027

    7.9.3    Market estimates and forecast, by end-use, 2016 - 2027

    7.10    Indonesia

    7.10.1    Market estimates and forecast, by product type, 2016 - 2027

    7.10.1.1    Market estimates and forecast, by diagnostics, 2016 - 2027

    7.10.2    Market estimates and forecast, by application, 2016 - 2027

    7.10.3    Market estimates and forecast, by end-use, 2016 - 2027

    Chapter 8   Company Profiles

    8.1    Qiagen Inc.

    8.1.1    Business overview

    8.1.2    Financial data

    8.1.3    Product landscape

    8.1.4    Strategic outlook

    8.2    Medtronic

    8.2.1    Business overview

    8.2.2    Financial data

    8.2.3    Product landscape

    8.2.4    Strategic outlook

    8.3    Pfizer Inc.

    8.3.1    Business overview

    8.3.2    Financial data

    8.3.3    Product landscape

    8.3.4    Strategic outlook

    8.4    Quest Diagnostics Inc

    8.4.1    Business overview

    8.4.2    Financial data

    8.4.3    Product landscape

    8.4.4    Strategic outlook

    8.5    Novartis

    8.5.1    Business overview

    8.5.2    Financial data

    8.5.3    Product landscape

    8.5.4    Strategic outlook

    8.6    Abbott Laboratories

    8.6.1    Business overview

    8.6.2    Financial data

    8.6.3    Product landscape

    8.6.4    Strategic outlook

    8.7    F. Hoffmann-La Roche AG

    8.7.1    Business overview

    8.7.2    Financial data

    8.7.3    Product landscape

    8.7.4    Strategic outlook

    8.8    bioMérieux SA

    8.8.1    Business overview

    8.8.2    Financial data

    8.8.3    Product landscape

    8.8.4    Strategic outlook

    8.9    Eli Lilly & Company

    8.9.1    Business overview

    8.9.2    Financial data

    8.9.3    Product landscape

    8.9.4    Strategic outlook

    8.10    AstraZeneca PLC

    8.10.1    Business overview

    8.10.2    Financial data

    8.10.3    Product landscape

    8.10.4    Strategic outlook

    8.11    Glaxosmithkline Plc.

    8.11.1    Business overview

    8.11.2    Financial data

    8.11.3    Product landscape

    8.11.4    Strategic outlook

    8.12    Cancer Genetics Inc.

    8.12.1    Business overview

    8.12.2    Financial data

    8.12.3    Product landscape

    8.12.4    Strategic outlook

    8.13    Cepheid Inc.

    8.13.1    Business overview

    8.13.2    Financial data

    8.13.3    Product landscape

    8.13.4    Strategic outlook

    8.14    Thermo Fisher Scientific Inc.

    8.14.1    Business overview

    8.14.2    Financial data

    8.14.3    Product landscape

    8.14.4    Strategic outlook

    8.15    Bristol-Myers Squibb

    8.15.1    Business overview

    8.15.2    Financial data

    8.15.3    Product landscape

    8.15.4    Strategic outlook

    8.16    Myriad Genetics Inc.

    8.16.1    Business overview

    8.16.2    Financial data

    8.16.3    Product landscape

    8.16.4    Strategic outlook
     


    Get this research report on Asia Pacific Precision Medicine Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]